GO:0005343 organic acid:sodium symporter activity

GO:0005343 organic acid:sodium symporter activity is a molecular function defined in the Gene Ontology as enabling the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: organic acid(out) + Na+(out) = organic acid(in) + Na+(in). This activity is fundamental to cellular metabolism because it allows cells to take up carboxylic acids, such as di- and tricarboxylates, against their concentration gradient by harnessing the electrochemical sodium gradient. Researchers study this term to understand how metabolic intermediates, neurotransmitters, and drugs are transported across plasma and organellar membranes. The activity is mediated by solute carrier (SLC) family proteins, including members of the SLC13, SLC6, SLC1, and SLC25 families. Because these transporters influence energy balance, neurotransmission, and detoxification, they are implicated in a wide range of physiological and pathological processes. In this article, we provide a research-grade overview of the mechanism, key genes, regulation, disease associations, and experimental methods for studying organic acid:sodium symporter activity, with a focus on how CRISPR-based models can accelerate discovery.

In our own words, GO:0005343 organic acid:sodium symporter activity is a molecular function in which a membrane-embedded protein binds an organic acid (a carboxylic acid-containing molecule) and a sodium ion on one side of the membrane and translocates both across the lipid bilayer in a coupled manner. The reaction is reversible in principle but in cells is driven by the sodium gradient, typically maintained by the Na+/K+-ATPase. The term encompasses symporters that may also be described as sodium/chloride-dependent organic acid cotransporters or sodium:dicarboxylate/tricarboxylate symporters. This activity is distinct from sodium-independent organic acid transport and from proton-coupled transport.

Organic acid:sodium symporter activity is essential for maintaining cellular levels of key metabolites, for neurotransmitter recycling, and for drug disposition. Because these transporters are expressed in the kidney, intestine, liver, brain, and mitochondria, their dysfunction can lead to systemic metabolic imbalances and neurological disorders. Understanding their mechanism and regulation is therefore critical for developing therapies that target transport pathways.

The following genes encode proteins that exhibit organic acid:sodium symporter activity or are directly involved in the transport process.

The activity of organic acid:sodium symporters is regulated at multiple levels. Gene expression can be induced by metabolic signals such as insulin and glucocorticoids. Membrane trafficking and surface retention are controlled by phosphorylation and ubiquitination. In the brain, transporter activity is modulated by neuronal activity and second messengers. Mitochondrial carriers are regulated by calcium and by the redox state.

Mutations in SLC13A5, which encodes a sodium-dependent citrate transporter, cause early infantile epileptic encephalopathy. Similarly, loss-of-function mutations in GABA and glutamate transporters (SLC6A1, SLC1A2) are associated with epilepsy and neurodevelopmental disorders. These findings highlight the importance of organic acid:sodium symporters in maintaining neuronal excitability.

Dysregulation of renal and hepatic organic acid transporters contributes to metabolic acidosis, hypercitraturia, and obesity. For example, SLC13A2 knockout mice exhibit altered citrate metabolism and are protected against diet-induced obesity. These transporters are therefore potential targets for metabolic disease therapy.

Cancer cells reprogram metabolism to support growth, and organic acid transporters such as SLC13A5 and SLC25A1 are upregulated in some tumors. They supply citrate and other intermediates for lipid synthesis and energy production. Targeting these transporters may offer therapeutic opportunities.

Radiolabeled or fluorescent organic acid uptake assays in cells or proteoliposomes measure the transport rate and substrate specificity. These assays can be coupled with sodium gradient manipulation to confirm sodium dependence.

Patch-clamp and two-electrode voltage clamp in Xenopus oocytes expressing the transporter can measure electrogenic transport and stoichiometry. This method provides real-time kinetics of coupled transport.

Cryo-electron microscopy and X-ray crystallography reveal the atomic structure of transporters in different states. These structures guide mutagenesis and drug design.

Genome-wide CRISPR knockout or activation screens can identify genes that regulate organic acid transport or sensitivity to transport inhibitors. This approach is powerful for discovering novel regulators.

Researchers studying organic acid:sodium symporter activity-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models that answer these questions.

Organic acid:sodium symporter activity (GO:0005343) is a fundamental molecular function that couples the transport of organic acids to the sodium gradient. It is mediated by a diverse set of SLC family proteins and plays critical roles in metabolism, neurotransmission, and disease. Understanding its mechanism and regulation requires a combination of biochemical, structural, and genetic approaches. CRISPR-based models, such as those provided by EDITGENE, offer powerful tools to dissect the causal roles of these transporters in health and disease.